Trials / Completed
CompletedNCT00084227
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
A Phase Ii/Iii, Randomized, Double Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 244 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin/Chloroquine | |
| DRUG | Atovaquone/Proguanil |
Timeline
- Start date
- 2004-07-01
- Completion
- 2005-07-01
- First posted
- 2004-06-11
- Last updated
- 2011-05-11
Source: ClinicalTrials.gov record NCT00084227. Inclusion in this directory is not an endorsement.